About this event

  • Date and time Thu 12 Nov 2020 from 6:00pm to 7:30pm
  • Location Online
  • Organised by Urology

With recent improvements in prostate cancer diagnostics, focal therapy has assumed increasing acceptance as a treatment option in many urology departments. This virtual MDT will review a number of real cases to explore the current status of focal therapy. 

The real cases have been selected to bring out some of the controversial questions which remain in the debate between the focal therapy enthusiasts and proponents of more radical treatment.    

Delegates will be given the opportunity to ask questions. CPD applied. 

During this webinar you will:

  • Learn what the current indications are for focal therapy
  • Understand the limitations of focal therapy
  • Appreciate the decision-making in some of the more controversial cases

Join in the conversation online using #RSMUrology
Follow us on Twitter: @RoySocMed and @RSMUrology

Key speakers

Hashim Ahmed

Professor Hashim U. Ahmed

Professor of Urology, Imperial College London, UK 

Speaker's biography

Professor Hashim U. Ahmed qualified from the University of Oxford where he attended St Peter’s College and Linacre College. Whilst he was a student he was awarded the William Osler Prize in Medicine. He then held house office posts in Queen Elizabeth Hospital, Birmingham and University Hospital Manchester before returning to Oxford for an anatomy prosector post. He then held senior house jobs in surgery on the Royal Free Hospital London rotation followed by specialist registrar posts at West Middlesex Hospital, Charing Cross Hospital and Imperial College London, University College Hospital and Watford General Hospital as part of the Imperial College urology rotation.

 

Professor Ahmed was a Pelican Cancer Foundation Research Fellow, this was followed by a Medical Research Council (MRC) Clinician Research Training Fellowship at University College London at which time a number of imaging and focal therapy trials began. His research interests are in health technology evaluation including multi-parametric magnetic resonance imaging (MRI), histoscanning, tissue type imaging, as well as therapeutic interventions such as high intensity focused ultrasound, irreversible electroporation, photodynamic therapy, cryotherapy and radiofrequency ablation. He has completed numerous phase I/II clinical trials evaluating the role of focal therapy in prostate cancer and is lead principal investigator and co-principal investigator in a number of multicentre trials including the UK National Institute for Health Research-Health Technology Assessment (NIHR-HTA) funded National Cancer Research Network (NCRN) PROMIS study evaluating the role of multi-parametric MRI in men with a raised PSA using template prostate mapping as the reference standard. Also for NCRN INDEX, a multicentre focal therapy study using high intensity focused ultrasound (HIFU) with three-year follow-up and NCRN FORECAST. He previously held a £1.2 million MRC Clinician Scientist Fellowship for five years and currently holds a £2 million Senior Clinical Research Fellowship from the Wellcome Trust.

 

Professor Ahmed has been visiting professor to University of California, Los Angeles as well as Tokyo, Weill-Cornell and Detroit universities and has given over 30 plenary lectures at national and international urology, oncology and imaging meetings. The team he led recently was awarded the BMJ/BMA Innovation Award 2015 and the Health Services Journal Acute Sector Innovation Award 2016.

Paul Cathcart

Consultant Urological Surgeon, Guys and St Thomas’ Hospital, UK

Dr Ajay Aggarwal

Dr Ajay Aggarwal

Consultant Clinical Oncologist at Guy’s & St Thomas’ NHS Trust, London and Associate Professor at the London School of Hygiene and Tropical Medicine, UK

Speaker's biography

Dr Ajay Aggarwal's main research areas are Health Services Research and Global Health and he is the current editor of the Journal of Cancer Policy. He has been the recipient of two fellowship awards from the National Institute for Health Research (NIHR) in 2014 and 2020. In his role as the Oncology Coordinator for the UK National Prostate Cancer Audit, he co-led the development and delivery of the first ever national public outcome reporting programme for radiotherapy. He also leads a real world data programme in prostate cancer evaluating the effectiveness of different treatment approaches. His research has contributed significantly to national and international policy discussion around the affordability of cancer care and the value of new technologies in cancer medicine which has influenced directly both WHO Cancer Drug Pricing and Benefits Taskforces, and the European Medicines Agency.

 

As co-chair of the Health Economics in Radiation Oncology (HERO) group within ESTRO (European Society for Radiation Oncology), he is co-leading the value-based health care initiative and working with the European Commission to support reimbursement policy for medical devices in cancer care. He has ongoing global health projects in South Africa and Zambia aimed at building radiotherapy capacity and cancer research capability.

Henry Tam

Consultant Radiologist, Imperial College Healthcare, UK 

Location

Online

Disclaimer: All views expressed in this webinar are of the speakers themselves and not of the RSM.

Special rates for difficult times 
The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s ​weekly COVID-19 Series ​webinars remain free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic.

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted.

All webinars will be available for registered delegates 30 days after on Zoom. The link will be sent 24 hours after the webinar takes place. 

This webinar will be recorded and stored by the Royal Society of Medicine and may be  distributed  in future on various internet channels. 

Man searching computer

Join the RSM and get unlimited digital learning and e-resources access

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy unlimited digital learning any time you need and access to e-journals, e-books and 7 huge medical databases to support your clinical decision-making and research.

Our e-resources are updated continuously to ensure you receive the cutting edge knowledge you need. 

 

Become a member